Publications by authors named "Giuseppe Spadaro"

Claim this Profile
S
Secondary antibody deficiencies: what's around the corner?
Gianluca Lagnese, Carla Messuri, Remo Poto, Gilda Varricchi, Giuseppe Spadaro

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Advanced Glycation End Products (AGEs) on Human Lung Macrophages: Implications for Pulmonary Inflammation.
Francesco Palestra, Gina Memoli, Leonardo Cristinziano, Anne Lise Ferrara, Laura Carucci, Giuseppe Spadaro

J Inflamm Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort.
Riccardo Senter, Andrea Zanichelli, Agolini Stefano, Francesco Arcoleo, Donatella Bignardi, Giuseppe Spadaro

Clin Exp Allergy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy.
Umberto Anceschi, Antonio Tufano, Davide Vitale, Francesco Prata, Rocco Simone Flammia, Giuseppe Spadaro

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney involvement and anemia in COVID-19 infection.
Guido Gembillo, Luigi Peritore, Giuseppe Spadaro, Felicia Cuzzola, Michela Calderone

World J Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling predictors of positive surgical margins in Retzius-sparing and anterograde robot-assisted radical prostatectomy: insights from a dual-centre learning curve experience.
Umberto Anceschi, Salvatore Basile, Francesco Prata, Valerio Cellini, Alberto Caviglia, Giuseppe Spadaro

J Robot Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Zhang et al.
Raffi Tachdjian, Aleena Banerji, Paula J Busse, Nancy Agmon-Levin, John Anderson, Giuseppe Spadaro

Pediatr Allergy Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli.
Francesco Palestra, Luca Modestino, Annagioia Ventrici, Arianna Monteforte, Gina Memoli, Giuseppe Spadaro

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Kidney Disease in Common Variable Immunodeficiency: a Multicenter Study.
Chiara De Renzis, Renato Finco Gambier, Antonietta Gigante, Carla Maria Deiana, Gianluca Lagnese, Giuseppe Spadaro

J Clin Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE.
Raffi Tachdjian, Aleena Banerji, Paula J Busse, Nancy Agmon-Levin, John Anderson, Giuseppe Spadaro

Pediatr Allergy Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat.
Andrea Zanichelli, Dario Cattaneo, Antonio Gidaro, Riccardo Senter, Francesco Arcoleo, Giuseppe Spadaro

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Link between obstructive uropathy and acute kidney injury.
Guido Gembillo, Giuseppe Spadaro, Domenico Santoro

World J Nephrol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab.
Danilo Di Bona, Massimo Bilancia, Claudia Crimi, Michelina Daddato, Alida Benfante, Giuseppe Spadaro

Clin Exp Allergy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dilemma of X-linked agammaglobulinemia carriers.
Federica Pulvirenti, Cinzia Milito, Francesco Cinetto, Giulia Garzi, Germano Sardella, Giuseppe Spadaro

J Allergy Clin Immunol Glob· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N-acylethanolamines in patients with hereditary angioedema due to FXII mutation.
Anne Lise Ferrara, Francesco Palestra, Fabiana Piscitelli, Angelica Petraroli, Chiara Suffritti, Giuseppe Spadaro

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization therapy in pregnant women with syphilis reporting allergy to penicillin: A case series.
Annunziata Carlea, Antonio Angelino, Laura Letizia Mazzarelli, Giuseppe Maria Maruotti, Caterina Fulgione, Giuseppe Spadaro

Eur J Obstet Gynecol Reprod Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study.
Ilaria Mormile, Maria Celeste Gigliotti, Anne Lise Ferrara, Roberta Gatti, Giuseppe Spadaro

Immunol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis.
Corrado Pelaia, Claudia Crimi, Alida Benfante, Maria Filomena Caiaffa, Raffaele Campisi, Giuseppe Spadaro

Respirology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.
Remo Poto, Leonardo Cristinziano, Gjada Criscuolo, Caterina Strisciuglio, Francesco Palestra, Giuseppe Spadaro

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.
Luisa Canè, Remo Poto, Francesco Palestra, Ilaria Iacobucci, Marinella Pirozzi, Giuseppe Spadaro

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.
Annalisa Villa, Cinzia Milito, Carla Maria Deiana, Renato Finco Gambier, Alessandra Punziano, Giuseppe Spadaro

J Clin Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
Cinzia Milito, Federica Pulvirenti, Giulia Garzi, Eleonora Sculco, Francesco Cinetto, Giuseppe Spadaro

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review.
Mario D'Onofrio, Daniele La Prova, Maria Rosaria Galdiero, Elena Cantone, Eugenio Tremante, Giuseppe Spadaro

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.
Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, Aikaterini Detoraki, Giovanni Sarnelli, Giuseppe Spadaro

Cells· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Andrea Portacci, Raffaele Campisi, Enrico Buonamico, Santi Nolasco, Corrado Pelaia, Giuseppe Spadaro

ERJ Open Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis